Esperion Therapeutics, Inc. Made Headway
Fri, May 01, 2026 at 07:37 PM
Esperion Therapeutics, Inc. (ESPR:NASDAQ) soared at $3.11, representing a gain of 55.5%. On Fri, May 01, 2026, ESPR:NASDAQ touched a New 2-Week High of $3.11. The stock appeared on our News Catalysts scanner on Fri, May 01, 2026 at 12:39 PM in the 'ACQUISITION' category. From Fri, Apr 17, 2026, the stock recorded 30.00% Up Days and 36.36% Green Days
About Esperion Therapeutics, Inc. (ESPR:NASDAQ)
Esperion Therapeutics Inc is a pharmaceutical company focused on developing and commercializing oral, low-density lipoprotein cholesterol, or LDL-C, lowering therapies for the treatment of patients with elevated LDL-C.
Top 10 Gainers:
- AIOS Tech Inc Cl A (AIOS:NASDAQ), 140.17%
- Cue Biopharma, Inc. (CUE:NASDAQ), 106.38%
- Esperion Therapeutics, Inc. (ESPR:NASDAQ), 55.5%
- Streamex Corp. (STEX:NASDAQ), 54.21%
- Ten-League International Holdings Limited (TLIH:NASDAQ), 50.8%
- Urban One, Inc. (UONE:NASDAQ), 39.24%
- DMC Global Inc. (BOOM:NASDAQ), 36.08%
- Pershing Square Inc. (PS:NYSE), 35.68%
- Atomera Incorporated (ATOM:NASDAQ), 35.57%
- Direct Digital Holdings, Inc. (DRCT:NASDAQ), 34.34%